195990 — ABPro Bio Co Balance Sheet
0.000.00%
- KR₩56bn
- KR₩65bn
- KR₩32bn
Annual balance sheet for ABPro Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 30,885 | 53,961 | 21,038 | 18,929 | 21,238 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,013 | 4,331 | 4,554 | 6,113 | 12,389 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 57,808 | 81,903 | 45,793 | 44,804 | 48,981 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 39,552 | 24,170 | 23,099 | 22,579 | 21,574 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 166,028 | 167,884 | 156,646 | 142,110 | 141,263 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14,831 | 29,760 | 16,009 | 17,925 | 21,015 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26,928 | 30,343 | 16,450 | 19,769 | 33,251 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 139,100 | 137,541 | 140,196 | 122,340 | 108,012 |
| Total Liabilities & Shareholders' Equity | 166,028 | 167,884 | 156,646 | 142,110 | 141,263 |
| Total Common Shares Outstanding |